Glioma
New glioma findings from A. Berrocal and co-authors described
Published in Clinical Oncology Week, March 8th, 2010
"This multicenter phase II study conducted by the Spanish Neuro-Oncology Group evaluated the activity of an extended, dose-dense temozolomide regimen in patients with temozolomide-refractory malignant glioma. Adult patients (at least 18 years of age) with WHO grade III or IV glioma and a Karnofsky Performance Status of 60 or higher were treated with temozolomide (85 mg/m(2)/day) for 21 consecutive days every 28-day cycle until disease progression or unacceptable toxicity," scientists in Valencia, Spain report.
"All patients had developed progressive disease either during or less than 3 months after completing previous temozolomide treatment. Forty-seven patients were...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
More Articles from Clinical Oncology Week
- American Cancer Society
Survey finds significant racial differences in lung cancer beliefs - American Cancer Society
Testosterone deficiency affects male cancer survivors' quality of life - American College of Radiology / American Roentgen Ray Society
MRI: Noninvasive diagnostic tool for diagnosing testicular cancer - American Gastroenterological Association
Reliable biomarkers needed for early detection of liver cancer - American Gastroenterological Association
Those who have colonoscopy performed by GIs less likely to develop colorectal cancer - Cold Spring Harbor Laboratory
Melanoma transcriptome reveals novel genomic alterations not seen before - More from this issue of Clinical Oncology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
